Recent US Food and Drug Administration (FDA) warnings that a popular over-the-counter cold remedy could cause loss of sense of smell in users have drawn attention to potential risks associated with so-called homeopathic remedies.
Such products are usually allowed to be marketed as remedies for an array of health conditions without first demonstrating their safety and efficacy to the FDA. However, in June the FDA warned consumers that zinc-containing Zicam products (Cold Remedy Nasal Gel, Zicam Cold Remedy Nasal Swabs, and Zicam Cold Remedy Swabs, Kids Size) could cause anosmia, and warned the manufacturer, Matrixx Initiatives (Scottsdale, Ariz), to stop marketing them. The children's product was no longer being sold at the time of the warning, and Matrixx Initiatives has since voluntarily recalled the other 2 products, but disputed that they pose a risk. The warnings have renewed debate about the safety and efficacy of homeopathic products and whether they should be subjected to closer oversight.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Graphic Jump Location
Homeopathic remedies receive far less scrutiny from the US Food and Drug Administration than pharmaceuticals, leaving many unanswered questions about their safety and efficacy.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.